Removal of Lateral Exostosis (Maxilla or Mandible) Template

Removal of lateral exostosis (maxilla or mandible).

RMH: Medical history reviewed/updates
Vitals: BP/pulse; other vitals if indicated

Site: Site/tooth area
Arch: Arch
Indication: Indication/diagnosis
Radiographs/images: Radiographs/images reviewed/taken and findings
Prosthesis fabrication.
Trauma from mastication.
Patient request.

Consent: Consent/PARQ reviewed; signed/verbally obtained

Anesthesia: Anesthetic used
Carps: Carpules/amount

Surgical procedure support: Specific site/teeth, indication, and medical necessity
Operative details: Surgical access, tissue/bone removed or repositioned, closure materials
Image/specimen support: Radiographs/photos/specimen/lab as applicable

Procedure:
Incision made.
Mucoperiosteal flap elevated.
Exostosis exposed.
Bone removed with bur/rongeurs.
Area smoothed and contoured.
Copious irrigation.
Flap repositioned.
Sutured with: Suture material/size
Hemostasis achieved.

Complications: None or describe.

Patient tolerance: Tolerance/response.

Post-op instructions: Instructions reviewed.
Rx: Prescription or none

NV: Next visit

Documentation requirements

D7471 documentation does three things: prove the bony mass is a lateral / buccal / off-midline exostosis (not a midline torus, not a fibrous tuberosity, not generalized ridge contour), prove a covered indication (most commonly pre-prosthetic preparation for a removable prosthesis), and prove the surgical procedure was actually performed — flap design, bony reduction, recontouring, primary closure. D7471 is a per-area code, so the chart must also clearly delineate which sites are being treated and bill them as separate line items where the carrier permits. A defensible note includes:

• Site and laterality — explicit anatomic location: which arch, which quadrant, buccal vs palatal/lingual, which teeth or edentulous span. "Buccal exostosis, maxillary right quadrant, buccal of #2-#5" beats "bony prominence, upper right." Bilateral or multi-quadrant cases must enumerate each site separately because billing is per area.
• Per-area delineation — when removing exostoses in more than one quadrant, document each quadrant or site as a discrete procedure. Most carriers pay D7471 per quadrant (some per discrete site / per arch — verify); a chart that lumps "removal of multiple exostoses, upper and lower" without site-level detail is at risk of being downgraded to a single line.
• Exostosis dimensions — measured in millimeters: anterior-posterior length, occlusogingival height, faciolingual width / projection. "Lobulated buccal exostosis, ~18 mm A-P x 4 mm projection from buccal cortex, occlusogingival ~6 mm" is concrete; "large bony bump" is not. Dimensions support medical necessity for excision rather than prosthesis modification.
• Exostosis shape / morphology — flat shelf, dome, nodular / lobulated, pedunculated. The morphology drives the surgical approach (rongeur removal of pedunculated exostoses, bur reduction for flat shelves) and predicts the risk of mucosal perforation over thin overlying mucosa.
• Indication / diagnosis — explicit, covered indication. The four reportable buckets are: (a) prosthetic interference with a planned or existing removable prosthesis flange or denture base — strongest carrier-acceptable indication; (b) traumatic — recurrent ulceration of overlying mucosa from mastication or sharp lobulated topography; (c) functional — interferes with a planned implant osteotomy, fixed-prosthesis emergence profile, periodontal surgical access, or hygiene access; (d) pathology-related — interference with another surgical procedure. "Pre-prosthetic — buccal exostoses prevent seating of planned mandibular partial denture flange (D5214), causing rocking and ulceration over the buccal of #28-#29" is the prototypical reimbursable indication.
• Prosthetic plan documentation — when the indication is pre-prosthetic, name the planned removable prosthesis code(s) (D5110, D5120, D5130, D5140, D5213, D5214, D5863, D5864). The same-claim or near-future presence of a removable prosthodontic code is the single strongest piece of medical-necessity evidence on review. For pre-existing dentures, document the date of fabrication, the specific area of acrylic relief or fracture, and any history of mucosal ulceration over the exostosis.
• Pre-op imaging — pre-op intraoral photo of the exostosis is the single most-requested piece of documentation when D7471 is reviewed. Periapical or panoramic radiographs (D0220 / D0230 / D0330) showing the bony prominence are useful but lateral exostoses often project poorly on 2D imaging. CBCT (D0364-D0368) is occasionally used when the exostosis is large or near vital structures (mental foramen for mandibular buccal exostoses, sinus floor for maxillary buccal exostoses); bill the imaging code separately and document the indication. A pre-op clinical photo labeled with patient identifier, date, and site (e.g., "buccal exostosis maxillary right, pre-op") is the strongest single piece of audit evidence.
• Medical and dental history — reviewed today; flag bisphosphonates / anti-resorptives (MRONJ risk for any oral surgical bone-removal procedure; nitrogen-containing IV bisphosphonates and denosumab the highest), anticoagulants (with INR or recent dose timing for warfarin / DOACs), antiplatelet therapy, head/neck radiation history (osteoradionecrosis risk), uncontrolled diabetes, immunosuppression, and IE prophylaxis indication when applicable.
• Vitals — pre-op BP and pulse; many state boards and most surgical practices require these on operative visits.
• Informed consent / PARQ — risks specific to lateral exostosis removal: mucosal perforation (the overlying mucosa can be thin, especially over pedunculated or lobulated exostoses), postoperative bleeding, mental nerve paresthesia (mandibular buccal exostoses near the mental foramen carry a small but real risk of injury during flap reflection or bur reduction), lingual nerve injury (rare for D7471 since this is buccal/lateral, not lingual — but worth noting for posterior mandibular sites), maxillary sinus exposure (rare but reportable for very large maxillary buccal exostoses near the sinus floor), flap dehiscence, prolonged healing, post-op pain and swelling, infection, need for additional surgery if recurrence (rare) or incomplete removal occurs, and alternatives (no treatment with prosthesis modification or relief, smaller staged reduction, OMS referral for very large or anatomically complex exostoses). Note signed vs verbal.
• Anesthesia — agent, concentration, vasoconstrictor, technique. Local infiltration of the buccal vestibule and palatal mucosa for maxillary sites; inferior alveolar nerve block plus long buccal infiltration for mandibular buccal sites; bilateral infiltration for bilateral cases. Document the carpule count and any sedation codes (D9223 / D9230 / D9243 / D9248) used separately.
• Surgical code support — the "exostosis removal" line — explicit operative description of: incision design (sulcular incision along the gingival margin with vertical releasing incisions one tooth mesial and distal to the exostosis, or a vestibular incision for edentulous spans); flap elevation (full-thickness mucoperiosteal flap reflected to expose the entire exostosis with ~2 mm of bone visible peripherally); bone removal technique (round bur, rongeur, or osteotome depending on morphology — pedunculated exostoses removed with rongeur, flat shelves reduced with bur, lobulated exostoses sectioned and removed in pieces); recontouring (round bur, bone file, or rongeur to achieve a smooth ridge with no sharp edges, blending into surrounding alveolar bone); irrigation (copious sterile saline throughout to prevent thermal injury and clear bony debris); closure (primary closure with interrupted or continuous sutures along the sulcular incision and at the releasing limbs).
• Surgical image support — intraoperative photo of the elevated flap and exposed exostosis before reduction is increasingly expected on review. A post-reduction photo confirming smooth contour and a post-op photo at suture-removal closes the loop. Photos labeled with patient identifier, date, and site.
• Specimen — bony fragments are typically discarded; submission to pathology is not routinely indicated for clinically obvious exostoses. Submit when the morphology is atypical, the clinical history is unusual (rapid growth, asymmetry, soft-tissue change), or the surgeon's index of suspicion for an osteoma or fibro-osseous lesion is non-zero. Document "specimen submitted to [lab] for histopathologic confirmation" or "specimen discarded — clinically diagnostic exostosis."
• Suture material and pattern — material (e.g., 4-0 chromic gut, 4-0 PGA, 3-0 silk), pattern, count. Resorbable suture preferred for buccal vestibular sites in patients unlikely to return for suture removal.
• Hemostasis — achieved; method if notable (pressure with gauze, gelfoam, electrosurgery for soft-tissue bleeders).
• Complications — explicit "None" or describe (mucosal perforation through thin overlying tissue with primary repair, transient mental-nerve paresthesia documented and patient counseled, intraoperative bleeding managed with hemostatic agent, incomplete reduction with staged plan).
• Patient tolerance / response — tolerated well, vitals stable, no adverse events, ambulatory dismissal with escort if sedated.
• Post-op instructions — soft diet 5-7 days; cold compresses first 24 h then warm; head elevation first 48 h; saltwater rinses starting 24 h post-op; gentle hygiene around the surgical site; avoid pulling the lip or cheek to inspect; return precautions (uncontrolled bleeding, severe disproportionate pain after 72 h, fever, foul taste or purulent discharge, persistent numbness of lip / chin for mandibular sites — mental nerve paresthesia warning, exposed bone). Verbal and written instructions documented.
• Prescriptions — analgesic regimen (ibuprofen 600 mg q6h prn ± acetaminophen 500 mg alternating per ADA / AAOMS NSAID-first guidance; opioid only when clinically warranted per practice protocol and state PMP rules); antibiotic per indication (no routine prophylaxis for healthy patients per AAOMS; consider for very large exostoses, prolonged operative time, immunocompromise, or active infection); chlorhexidine 0.12% rinse BID for plaque control around sutures. Document drug, dose, route, frequency, duration, and counseling on each.
• Next visit — post-op check at 7-10 days for suture inspection (most chromic resorbs in this window); 3-week follow-up to assess complete mucosal coverage and ridge contour; prosthetic milestone linked to the indication (e.g., "denture impression appointment scheduled for 4-6 weeks post-op once mucosa is fully healed and ridge contour is stable").
• Provider signature and any auxiliary operator initials.

Two phrases that defuse the most common audit questions on D7471: an explicit "interferes with planned removable prosthesis flange" statement linked to a same-arch removable prosthodontic code (D5110 / D5120 / D5213 / D5214), and explicit per-site documentation with dimensions supporting that each bony prominence billed is a discrete exostosis large enough to require excision rather than prosthesis modification.

Common denial reasons

D7471 sits in the carrier "always-review" tier of pre-prosthetic surgical codes and carries meaningful audit exposure. The most frequent reasons it is denied, downgraded, or recouped:

• No documented prosthetic indication — the dominant denial. Chart cites "patient request" or "for cosmesis" with no removable prosthodontic plan, no documented mucosal ulceration, no functional impairment. Carrier denies as not medically necessary / cosmetic. Pair every D7471 claim with at least one covered indication (prosthetic interference, trauma from mastication, functional impairment, pathology-related interference).
• No same-arch removable prosthesis on file or planned — even with a covered indication on paper, carriers route D7471 to review when there is no D5110 / D5120 / D5130 / D5213 / D5214 on the recent claim history or treatment plan. Submit the prosthetic plan with the original claim or pre-determination.
• Site coded as D7471 but actually D7472 or D7473 — a midline palatal torus mis-coded as D7471 (should be D7472) or a lingual mandibular torus mis-coded as D7471 (should be D7473). Carrier re-codes; D7472 / D7473 generally pay at different allowables than D7471 depending on the plan.
• Site coded as D7471 but actually alveoloplasty — generalized ridge recontouring with no discrete bony mass billed as D7471. Carrier re-codes to D7310 / D7311 / D7320 / D7321 (lower allowable) or denies.
• Multiple D7471 line items without per-site documentation — billing two or four D7471 lines without explicit per-site dimensions and indication. Carrier downgrades to a single line per arch or per quadrant. Document each site discretely.
• Missing exostosis dimensions — auditors treat absent measurement as a presumption that the bony prominence is small enough to manage with prosthesis relief rather than removal. "Lobulated exostosis" is not a measurement; "~18 mm A-P x 4 mm projection x 6 mm occlusogingival" is.
• No pre-op intraoral photo or imaging — the single most-requested piece of documentation when D7471 is reviewed. Carriers want to see the exostosis before the surgery.
• No flap technique or operative detail — chart says "exostosis removed" without incision design, flap elevation, reduction technique, or recontouring. Carrier downgrades to "incidental bone removal" bundled into a same-DOS extraction or denies for insufficient documentation.
• Default-template chart note — identical D7471 narrative across patients, no patient-specific dimensions or site detail. Medicaid MCO recoupment programs flag template-fingerprint patterns.
• Cosmetic / "carcinophobia" framing — chart cites only patient anxiety about the prominence, with no clinical indication. Almost universally denied.
• Same-DOS bundling with D7140 / D7210 (extractions) on the same site — bone reduction incidental to an extraction is bundled into the extraction code. D7471 must be a discrete exostosis at a distinct site or clearly separable from the extraction socket recontouring.
• Same-DOS bundling with D7310 / D7311 same quadrant — alveoloplasty of the area encompassing the exostosis is often bundled into D7471 (or vice versa). Bill alveoloplasty only when performed on a distinct quadrant or set of teeth/sites separate from the exostosis removal.
• Missing pathology disposition — chart silent on whether bony fragments were submitted or discarded. Most fragments are discarded as clinically obvious exostosis, but the chart should state the disposition.
• Operator signature / initials missing — auto-flagged by automated audit systems.

Related templates